Endpoints has more than 163,000 subscribers and distributes content via its daily news reports and website, and at in-person and online events.
This acquisition marks a significant milestone in the FT’s expansion in the U.S., where Endpoints is based, and deepens the FT’s coverage of the dynamic biopharma sector.
“We’re thrilled to invest in Endpoints, a fast-growing business with a robust reputation for delivering quality news to audiences across the biopharma ecosystem,” said FT Group CEO John Ridding in a statement. “There is strong alignment between Endpoints and the FT in terms of mission, business model and focus on reader revenues. This acquisition also supports our ambitions to reach new audiences in innovative sectors and grow our footprint in the U.S.”
Endpoints was founded seven years ago.
The Wall Street Journal is seeking an experienced and driven investigative reporter to join our…
MarketWatch seeks an ambitious reporter to join its technology team to cover the business interests…
Former CNET reporter Laura Hautala has become the opinion editor at The News Tribune in Tacoma, Washington.…
Joel Rubin, the deputy business editor at the Los Angeles Times, is joining Politico as…
Sidney Rutberg, the highly respected and longtime financial editor and columnist for Fairchild Publications, March…
Ethan Alter of TVNewser profiles Fox Business Network anchor Charles Payne, who has been an advocate…